Insta
Covid-19 vaccine - representative image (Twitter)
The Uttar Pradesh government led by Yogi Adityathan has allowed the phase-3 trial of "Covaxin", the anti-COVID-19 vaccine, in Lucknow and Gorakhpur.
This report says: Additional Chief Secretary (Medical and Health) Amit Mohan Prasad conveyed the government's permission to test the anti-COVID-19 vaccine in the two cities through a letter to Bharat Biotech International Limited's director V Krishna Mohan.
The vaccine is currently being tested by Bharat Biotech Ltd - in a collaboration with the Indian Council of Medical Research (ICMR).
Amit Mohan Prasad, who is Additional Chief Secretary (Medical and Health), has conveyed the government's permission to test the anti-COVID-19 vaccine in a letter to V Krishna Mohan, who is director, Bharat Biotech International Limited.
He says in the letter: "Kindly refer to your letter dated September 19, 2020 for permission and facilitation to initiate the COVAXIN Phase 3 Efficacy and Safety clinical trials in Uttar Pradesh. It has been decided to allow Bharat Biotech to conduct Phase-3 trial in Lucknow and Gorakhpur."
He adds, "All permission will have to be obtained by you and all safety and other protocols will have to be followed as per the guidelines of the Government of India for conducting clinical trials."
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest